Voltar à classificação

Chewy Inc (CHWY)

Subavaliada
Consumer CyclicalInternet RetailUnited States

Fundamental

86

Preço

$17.84

Capitalização de Mercado

$7.48B

Parte 1 · Quanto vale a empresa

Visão Geral

Chewy is a United States online retailer of pet food, pet supplies, pet medications and pet health services, selling through chewy.com and its mobile app to roughly 21.3 million active customers in the US and Canada. The 10-K for the fiscal year ended 1 February 2026 describes an assortment of about 190,000 items from around 4,000 brands, plus Chewy's own private labels (Frisco, American Journey, Tylee's, Vibeful, Get Real). Chewy operates its own fulfilment-centre network, positioned so that most of the US population can be reached overnight, and has extended beyond boxes of kibble into a licensed pharmacy, telehealth ('Connect with a Vet'), insurance and wellness plans (CarePlus) and 18 Chewy Vet Care clinics. Net sales were $12.60 billion in fiscal 2025, up 6.2% on the prior year.

Como gera receita

Almost all revenue comes from selling physical goods online: the customer pays at checkout, revenue is recognised when the order ships from a Chewy fulfilment centre and is delivered, and shipping fees charged to the customer are part of net sales. The engine underneath is Autoship, a subscription that re-orders consumables on a fixed schedule at a small discount: Autoship customer sales were $10.50 billion in fiscal 2025, or 83.3% of net sales. Smaller and newer streams — prescription pharmacy, veterinary clinics, insurance and wellness plans, and an advertising business that sells placement on Chewy's site to its own vendor partners — sit on top of the same customer base. This is a thin-margin, high-volume model: gross margin was 29.8% in fiscal 2025 and net income $222.8 million on $12.60 billion of sales, so profit depends on order density and logistics efficiency rather than on price.

Vantagem competitiva

Custos de mudança · Estreita

Chewy's advantage is habit rather than exclusivity. Once a pet parent has set up Autoship — with the pet's profile, the brand and bag size it tolerates, a delivery cadence and often a repeat prescription on file — reordering elsewhere means rebuilding all of that for a product that is identical wherever it is bought. The result is visible in the numbers: 83.3% of fiscal 2025 net sales came through Autoship, and the customer base grew 4.0% to 21.3 million. That is a real but modest barrier. Nothing stops Amazon, Walmart or a big-box chain from stocking the same brands at the same price, the 10-K's own risk factors describe the pet category as intensely competitive, and Chewy's scale in fulfilment is large in pet supplies but small next to the general-merchandise networks it competes with. Hence narrow, not wide.

O que impulsiona a procura

Moderadamente cíclico

Demand is anchored by a biological fact: a dog eats the same amount whether the economy is expanding or contracting, and medication for a chronic condition is not postponed. That is why consumables and pharmacy give Chewy a steady base and why 83.3% of fiscal 2025 sales arrived on a subscription schedule. The cyclical part sits around the edges. Hardgoods — beds, crates, toys, tech — are deferrable, and the flow of new pets is itself cyclical: adoptions surged during the pandemic and slowed afterwards, and each new pet is what starts a multi-year stream of food orders. So the installed base is defensive, while growth in the installed base is not. In a downturn Chewy tends to keep its revenue and lose its growth rate, and shoppers trade down to cheaper brands, which affects the mix as well as the volume.

Principais riscos

  • Growth may not continue at historical rates — The company states that its recent growth rate may not be sustainable and that it may fail to acquire new customers or retain existing ones at an acceptable cost. With growth of 6.2% in fiscal 2025 the business already depends more on spending per existing customer than on new customers, and the filing warns that the addressable market it estimates may itself be wrong.
  • Dependence on a few large suppliers — Chewy buys from hundreds of vendors but discloses that products from its three largest vendors accounted for approximately 39% of net sales in fiscal 2025 — the same share as in each of the two preceding years. The risk factors note that Chewy has no long-term guarantee of supply and that losing a major brand, or losing favourable terms on it, would be difficult to replace with an equivalent product.
  • Shipping and fulfilment — The filing lists disruptions to shipping arrangements, rising carrier costs and the difficulty of sizing and optimising the fulfilment-centre network among its principal risks. Pet food is heavy and low-value per kilo, so freight is a structural cost rather than a line item that can be squeezed away.
  • Intense competition in the pet category — Under 'Risks Related to Our Industry' the company describes the pet products market as highly competitive, against general online retailers, mass merchants, grocery chains and specialty pet stores, several of which are considerably larger and can sustain lower prices.
  • Regulation of the pet health and pharmacy business — Selling prescription medication and operating veterinary services brings state pharmacy licensing rules, the need for valid veterinarian authorisation on each prescription, and regulation of pet insurance. The company flags compliance cost and the risk of falling foul of these rules as a specific risk factor.
  • Cybersecurity and personal data — Chewy holds payment details, purchase histories and — through the pharmacy — health records for millions of customers, and depends on third-party SaaS platforms and network infrastructure. Breaches, outages at those providers and tightening privacy and marketing regulation are all disclosed risks.
  • Controlled company and share overhang — The company reports risks tied to its controlling stockholders: a dual-class structure, 'controlled company' status with the reduced governance requirements that follow, potential conflicts of interest, and the prospect of substantial future sales of stock by BC Partners affiliates.
  • Economic conditions and consumer spending — The filing cites uncertain economic and market conditions among its risks, along with merchandise returns and refunds. Food and medication are largely non-discretionary, but beds, toys and other hardgoods are not, and pet adoption itself slows when households feel poorer.

Concentração de clientes

There is no customer concentration to speak of, and the 10-K discloses none: Chewy sells to 21.3 million active customers, each spending a few hundred dollars a year, so no single buyer is material. The concentration in this business runs the other way, on the supply side — products from the three largest vendors accounted for approximately 39% of net sales in fiscal 2025. A beginner should read the risk as leverage held by a handful of pet-food brands over Chewy's shelf, not as dependence on a few big accounts.

Os argumentos a favor

Buyers argue that Chewy has quietly become a subscription business wearing a retailer's clothes: 83.3% of fiscal 2025 sales came through Autoship, revenue that repeats without being re-won each quarter, and the active customer base still grew 4.0% to 21.3 million. They point to gross margin rising to 29.8% and to the newer, higher-margin layers — pharmacy, the advertising business sold to Chewy's own vendors, insurance and the vet clinics — as evidence that the same customer can be worth more each year without much extra freight. They also note that the category is among the more resistant to recession, since pet food and medication are bought regardless, and that after years of building fulfilment capacity the heaviest infrastructure spending is behind the company.

Os argumentos contra

Sellers fear that this is a heavy, low-margin logistics operation selling commodities it does not control. Net sales grew 6.2% in fiscal 2025 while net income fell to $222.8 million from $392.7 million — the prior year having been flattered by a one-off tax benefit — and share-based compensation and related taxes of $311.2 million exceeded net income, which they read as real cost paid in shares rather than cash. Roughly 39% of what Chewy sells comes from three vendors who could change terms or sell directly. The goods themselves are identical to what Amazon, Walmart and the big-box chains ship, and those rivals can absorb thinner margins on pet food to defend a wider basket. Finally, the growth in active customers is slower than it was, so more of the story now rests on persuading existing households to spend more on services Chewy is still building out, and on the dual-class structure and BC Partners' remaining stake staying quiet.

Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users

P/E: 20.0Score: 69Market cap: $2.69T

Amazon is the other half of the US online pet-supply duopoly, selling the same food, litter and accessories to the same households and using Subscribe & Save against Chewy's Autoship, while Amazon Pharmacy now pushes into pet prescriptions too.

P/E: 37.7Score: 49Market cap: $853.59B

Walmart sells pet food and supplies at scale in its supercenters and on walmart.com, and is one of the destinations Chewy's departing customers name most often when they leave over price.

P/E: 15.3Score: 58Market cap: $16.38B

Tractor Supply's farm-and-feed stores and website make pet and animal food their single biggest category, competing for the bulk-buying pet owner in rural and suburban America that Chewy serves by parcel.

Petco Health and Wellness Company, Inc.WOOF

Petco chases the same pet parents with petco.com, its own delivery and subscription programme and in-store veterinary clinics, overlapping with Chewy across retail, pharmacy and vet services alike.

PetSmart LLCNot tracked

PetSmart is the largest US pet-specialty chain and Chewy's former parent, competing for the same recurring food and supplies spend through its stores and its own e-commerce and autoship offering.

PetMed Express, Inc. (1-800-PetMeds)PETS

PetMed Express is a pure-play online pet pharmacy selling the same prescription medicines, parasite preventives and supplements that Chewy Pharmacy ships to the same households.

Balanço & Liquidez

Receita

$13.07B

Últimos 12 meses (até 02/08/2026)

Resultado Líquido

$274M

Últimos 12 meses (até 02/08/2026)

Fluxo de Caixa Livre

$562M

Capital Próprio Total

$498M

Passivo Total

$2.87B

Rácio de Liquidez

0.84

Cobertura de Juros

28.79

Dívida/EBITDA

3.03

Resultados Por Ação

Receita & Resultado Líquido

Fluxo de Caixa Livre

Decomposição dos Resultados

Demonstração histórica

Margens ao longo do tempo

A dívida ao longo do tempo

Quanto pesa a dívida

Grelha do crescimento

Crescimento — Receitas

Estimativa de Valor Justo

Caso geralSubvalorizada

Valor Justo

$20656226.00

Preço Atual

$17.84

Margem de Segurança

+100.0%

Intervalo de Valor Justo

$13426547.00 - $27885906.00

Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.

Métodos de Estimativa

Preço-alvo dos analistas:$28.82
Fluxo de caixa descontado (DCF):$82624846.55
Multiplicador de lucros (P/E):$15.50
Fórmula de crescimento de Graham:$10.58
Valor da capacidade de gerar lucro (EPV):$5.73
P/B justificado:$7.67
Desconto de dividendos (Gordon):Dados insuficientes para o calcular
P/FFO, fundos de operações:$56336000.00
Lucros de meio de ciclo:Dados insuficientes para o calcular
Multiplicador sobre as receitas:$54.62
Consenso dos Analistas:Compra Forte (27B / 8H / 0S)
Última Surpresa de Resultados:+9.29%

Métricas de Avaliação

Rácio P/E

27.58

ROE

44.7%

Rácio P/B

0.00

P/FCF

0.00

Margem Bruta

29.9%

ROIC

16.9%

Radar de Rentabilidade

Criação de Valor (Vantagem Competitiva)

ROIC

16.9%

WACC

10.3%

ROIC − WACC

+6.6 pp

O ROIC supera o custo do capital — a empresa está a criar valor para os acionistas.

Critérios de Análise Fundamental

Aprovado (18)

  • EPS shows upward trend
  • ROIC 16.9%
  • P/FCF 0.00
  • P/B Ratio 0.00
  • Positive Free Cash Flow
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Price below Graham Number
  • DCF valuation (Undervalued)
  • ROE 62.1%
  • Revenue Growth 5Y 12.0%
  • Analyst Consensus 77% Buy
  • Earnings Quality (OCF/NI) 2.62
  • Share Dilution -0.7%
  • Net Margin Trend 2.1% vs 1.2%
  • Piotroski F-Score 7/9

Reprovado (7)

  • Price CAGR -4.87%
  • Gross Margin 29.9%
  • Debt/Equity ratio
  • Operating Margin 2.5%
  • CapEx intensity
  • Low reliance on intangibles
  • Earnings Surprise avg -1.3%

Indisponível (2)

  • Dividend Payout NaN%
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-Score

7/9

Saúde financeira sólida

score
criteria

Qualidade dos Resultados

2.62

Alta qualidade: resultados respaldados por caixa

Diluição de Ações

-0.7%

A recomprar ações. Favorável ao acionista

Participações institucionais

Governação

Equipa Executiva

NomeCargoIdade
Mr. Sumit SinghCEO & Director45
Mr. William G. BillingsChief Accounting Officer49
Mr. Ryan CohenCo-Founder39
Mr. Christopher S. DeppeChief Financial Officer45
Mr. Scott AndersonChief Operating Officer-
Yunyan WangChief Technology Officer-
Natalie NowakHead of Investor Relations-
Mr. Da-Wai Hu J.D.General Counsel & Secretary50
Heather SmedstadChief Human Resources Officer-
Ms. Aseemita MalhotraPresident of Chewy Health-

Risco de Auditoria

5

Risco do Conselho

10

Risco de Remuneração

10

Risco dos Direitos dos Acionistas

10

Parte 2 · O preço e o momento de entrar

Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.

Documentos

  • Relatório anual (10-K)

    Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.

    Arquivado em 2026-03-25

    Ver documento
  • Relatório trimestral (10-Q)

    Uma atualização sobre o desempenho financeiro dos últimos três meses.

    Arquivado em 2026-09-09

    Ver documento
  • Relatório de fato relevante (8-K)

    Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.

    Arquivado em 2026-09-09

    Ver documento

via SEC EDGAR

Histórico de Resultados

via SEC EDGAR

Latest News

Recent headlines for CHWY, sourced from Markets Gazette.

  • 20d agoNEGATIVE
    Chewy paga dazio con un dowgrande da JP Morgan

    Chewy Inc. shares experienced a significant decline of 4.36% on Wall Street following a downgrade by JP Morgan. The investment bank revised its recommendation for the online pet food retailer to 'underweight' from 'neutral', signaling a less optimistic outlook. This downgrade suggests potential headwinds for Chewy, possibly related to competitive pressures, slowing growth, or margin concerns, which could impact its future performance and investor sentiment.

  • 6/11/2026NEGATIVE
    Chewy Flags Weaker Consumer, Trims Guidance Despite Topping Q1 Estimates

    Chewy Inc. (NYSE: CHWY) reported Q1 results that surpassed analyst estimates, but the company's shares declined due to concerns over weakening consumer spending. Management has consequently trimmed its full-year guidance, signaling a more cautious outlook for the remainder of the fiscal year. While the company demonstrated resilience in the latest quarter, the forward-looking guidance adjustment and the acknowledgment of a tougher consumer environment suggest potential headwinds. Investors will be monitoring Chewy's ability to navigate these macroeconomic challenges and maintain its market position.

  • 6/10/2026NEUTRAL
    Chewy Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    Chewy Inc. is poised for its Q1 earnings report, with analysts forecasting earnings per share of 28 cents, a decrease from 35 cents in the prior year. Despite the projected earnings decline, the company has a track record of exceeding revenue estimates. Recent analyst actions include Deutsche Bank initiating coverage with a 'Buy' rating in March 2022 and RBC Capital initiating coverage with an 'Outperform' rating in January 2022. However, Piper Sandler downgraded the stock from 'Overweight' to 'Neutral' in January 2022. Investors will be closely watching revenue performance and management's outlook for future growth.

  • 5/19/2026NEGATIVE
    Chewy Stock Is Hit New 52-Week Low On Tuesday - Here's Why

    Chewy Inc. (NYSE: CHWY) shares plunged to a new 52-week low of $19.74 on Tuesday, signaling significant investor concern. While the article does not detail the specific reasons for the decline, it references updated analyst perspectives from Citigroup. This price action suggests that recent analyst ratings or outlooks may have turned bearish, potentially due to concerns over competitive pressures, slowing growth, or profitability challenges within the online pet retail sector. Investors should monitor future earnings reports and management commentary for clarity on the underlying issues impacting Chewy's valuation.

  • 3/26/2026NEGATIVE
    These Analysts Cut Their Forecasts On Chewy Following Q4 Results

    Despite Chewy (NYSE:CHWY) exceeding Q4 expectations and issuing robust fiscal 2026 guidance, several analysts have notably reduced their price targets for the stock. This divergence suggests that while the company's operational performance met or surpassed immediate forecasts, the forward-looking outlook or broader market conditions may be prompting a more cautious stance from analysts. Investors should monitor analyst commentary for specific reasons behind these target revisions, which could signal underlying concerns about future growth drivers or competitive pressures.

  • 3/25/2026POSITIVE
    Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

    Chewy Inc. shares experienced a significant surge of 14% following the release of upbeat earnings, contributing to a broader positive sentiment in the US stock market. The Dow Jones Industrial Average climbed over 300 points, indicating strong investor confidence. This performance by Chewy suggests robust consumer spending in the pet care sector, potentially signaling a healthy business model and effective operational strategies. Investors are likely to view this as a positive indicator for future growth and profitability, especially given the company's recent performance.

  • 3/24/2026NEGATIVE
    Chewy Q4 Preview: Pet Stock Hits 52-Week Low, Market Expert Says Earnings Are 'Prove It' Moment

    Chewy Inc. shares have recently touched new 52-week lows, signaling significant investor concern ahead of its Q4 earnings report. The company's stock performance indicates a challenging period, with the upcoming earnings release being a critical 'prove it' moment for management. Investors will be scrutinizing key metrics, including customer retention, average order value, and profitability, to gauge the company's ability to navigate current market conditions and demonstrate a clear path to sustained growth. Any miss on expectations could further pressure the stock.

  • 3/16/2026NEUTRAL
    Chewy Is Down 23% in 2026. Is This a Once-in-a-Lifetime Buying Opportunity?

    Chewy Inc. (CHWY) shares have experienced a significant downturn, declining 23% year-to-date in 2026. This underperformance raises questions about its current valuation and future prospects. While the stock's recent trajectory is negative, the article poses whether this steep drop presents a unique investment opportunity for potential buyers. Investors are advised to scrutinize the company's fundamentals, competitive landscape, and growth catalysts to determine if the current price reflects an undervalued asset or continued challenges.

via Markets Gazette